President Donald Trump’s support appears to be wavering for his nominee to head the Drug Enforcement Agency, who had a hand in legislation that weakens law enforcers’ ability to crack down on pharmaceutical companies.

President Donald Trump’s support appears to be wavering for his nominee as national drug czar, who had a hand in legislation that weakens law enforcers’ ability to crack down on pharmaceutical companies.

Trump on Monday called his Office of National Drug Control Policy nominee, Rep. Tom Marino (R-Pa.), a “great guy” and one of his earliest supporters. But he said a weekend report by The Washington Post and “60 Minutes” revealing Marino’s role in the industry-friendly legislation raises questions.

“We’re going to be looking into Tom,” Trump said at a news conference. “We’re going to look into the report, we’re going to take it very seriously.” He said his administration would declare the opioid epidemic a national emergency next week ― something he originally promised in August.

“This country and, frankly, the world has a drug problem,” Trump said. “We’re going to do something about it.”

Approximately 142 Americans die daily due to opioid addiction, an Opioid Commission report revealed in August. The amount of opioids prescribed in 2015 “enough for every American to be medicated around the clock for three weeks.”